We are live on ! Find out more
Royal Bank of Canada

Royal Bank of Canada Portfolio holdings

AUM $570B
1-Year Est. Return 27.57%
 

Royal Bank of Canada (RBC), founded in 1864 and headquartered in Toronto, is Canada’s largest bank by market capitalization and one of the leading financial institutions in North America, offering a comprehensive suite of services including personal and commercial banking, wealth management, insurance, and capital markets. Managing hundreds of billions in assets, RBC serves millions of clients globally, with a significant presence in the U.S. and Caribbean through subsidiaries like RBC Wealth Management and City National Bank. Known for its stability and consistent profitability, RBC has earned a reputation as a conservative yet innovative bank, expanding its digital offerings and sustainability initiatives in recent years. With a strong focus on customer service and a robust international footprint, RBC remains a cornerstone of the Canadian and global financial systems.

This Fund
S&P 500
This Quarter Est. Return
+4.82%
1 Year Est. Return
+27.57%
3 Year Est. Return
+75.99%
5 Year Est. Return
+94.97%
10 Year Est. Return
+325.25%
AUM
$228B
AUM Growth
+$19.5B
Cap. Flow
+$9.66B
Cap. Flow %
4.24%
Top 10 Hldgs %
19.68%
Holding
7,447
New
331
Increased
2,461
Reduced
3,156
Closed
486

Sector Composition

Rank Sector Weight
1 Financials 21.58%
2 Energy 8.65%
3 Industrials 8.54%
4 Technology 7.61%
5 Communication Services 7.33%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EPIX
5801
DELISTED
ESSA Pharma
EPIX
$9K ﹤0.01%
2,132
+1,567
+277% +$8.15K
GSJY icon
5802
Goldman Sachs ActiveBeta Japan Equity ETF
GSJY
$87.3M
$9K ﹤0.01%
+277
New +$9.12K
IOVA icon
5803
Iovance Biotherapeutics
IOVA
$3.05B
$9K ﹤0.01%
1,068
-5,273
-83% -$42.3K
MCB icon
5804
Metropolitan Bank Holding Corp
MCB
$1.17B
$9K ﹤0.01%
+215
New +$9.23K
NX icon
5805
Quanex
NX
$1B
$9K ﹤0.01%
389
-3,072
-89% -$68.1K
PARAA
5806
DELISTED
Paramount Global Class A
PARAA
$9K ﹤0.01%
155
-99
-39% -$5.75K
PCQ
5807
Pimco California Municipal Income Fund
PCQ
$168M
$9K ﹤0.01%
502
-2,000
-80% -$34.5K
RMTI icon
5808
Rockwell Medical
RMTI
$29.6M
$9K ﹤0.01%
13
-27
-68% -$19K
TOVX icon
5809
Theriva Biologics
TOVX
$10.6M
$9K ﹤0.01%
2
-1
-33% -$6.25K
UGP icon
5810
Ultrapar
UGP
$6.22B
$9K ﹤0.01%
800
-18,884
-96% -$218K
VTLE
5811
DELISTED
Vital Energy
VTLE
$9K ﹤0.01%
40
-19,601
-100% -$4.3M
WTV icon
5812
WisdomTree US Value Fund
WTV
$3.4B
$9K ﹤0.01%
216
QCLS
5813
Q/C Technologies Inc
QCLS
$22.7M
0
ONC
5814
BeOne Medicines Ltd
ONC
$40.6B
$9K ﹤0.01%
96
-111
-54% -$10.2K
BEST
5815
DELISTED
BEST Inc. American Depositary Shares, each representing twenty (20) Class A Ordinary Shares
BEST
$9K ﹤0.01%
50
+25
+100% +$5.28K
VBIV
5816
DELISTED
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
$9K ﹤0.01%
74
-71
-49% -$8.73K
SP
5817
DELISTED
SP Plus Corporation
SP
$9K ﹤0.01%
262
-1,389
-84% -$54K
AAU
5818
DELISTED
Almaden Minerals Ltd
AAU
$9K ﹤0.01%
8,498
+383
+5% +$382
NIB
5819
DELISTED
iPath Bloomberg Cocoa Subindex Total Return ETN due June 24, 2038
NIB
$9K ﹤0.01%
375
-75
-17% -$1.86K
NKG
5820
DELISTED
Nuveen Georgia Quality Municipal Income Fund
NKG
$9K ﹤0.01%
700
OBSV
5821
DELISTED
ObsEva SA Ordinary Shares
OBSV
$9K ﹤0.01%
+875
New +$8.89K
RADA
5822
DELISTED
Rada Electronic Industries Ltd
RADA
$9K ﹤0.01%
+3,000
New +$9.8K
DRNA
5823
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
$9K ﹤0.01%
1,016
+1,007
+11,189% +$7.41K
NEOS
5824
DELISTED
Neos Therapeutics, Inc
NEOS
$9K ﹤0.01%
863
-2,371
-73% -$22.8K
PES
5825
DELISTED
Pioneer Energy Services Corp.
PES
$9K ﹤0.01%
2,980
+2,066
+226% +$4.51K

Similar funds

Royal Bank of Canada's Q4 2017 Portfolio in Review

As of Q4 2017, Royal Bank of Canada held 7,447 positions worth $228B, up 9.4% from $208B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Royal Bank of Canada deployed $9.66B of net new capital in Q4 2017, opening 331 new positions and adding to 2,461 existing holdings. Its largest new stake was Maxar Technologies Inc. Common Stock: 2,562,561 shares worth $165M.

By sector, the portfolio is most concentrated in Financials at 22% of assets, down from 22% a quarter earlier, followed by Energy and Industrials.

On the sell side, the largest reduction was iShares Core S&P 500 ETF, an estimated $611M trimmed.

  • Royal Bank of Canada's largest Q4 2017 buy was Maxar Technologies Inc. Common Stock: 2,562,561 shares worth $165M.
  • Royal Bank of Canada added most to State Street SPDR S&P 500 ETF Trust in Q4 2017, an estimated $2.31B increase.
  • Royal Bank of Canada's biggest Q4 2017 reduction was iShares Core S&P 500 ETF, cutting an estimated $611M.
  • Royal Bank of Canada fully exited Kite Pharma, Inc. in Q4 2017, selling an estimated $144M.
  • Royal Bank of Canada's ten largest holdings make up 20% of its $228B portfolio in Q4 2017.
  • Royal Bank of Canada opened 331 new positions and closed 486 in Q4 2017.
  • Royal Bank of Canada's portfolio value rose 9.4% quarter-over-quarter to $228B.

Based on Royal Bank of Canada's 13F filing for Q4 2017, filed 14 Feb 2018.